No Photo Available

Last Update

2017-02-12T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Ivan Horak?

Dr. Ivan D. Horak

Chief Scientific and Medical Officer

Symphogen Inc

Direct Phone: +45 ** ** ** **       

Email: i***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Symphogen Inc

50 Division St Suite 503

Somerville, New Jersey 08876

United States

Company Description

Symphogen is a private biopharmaceutical company leading the field of recombinant antibody mixtures for therapeutic use in oncology. The European-based company is developing next-generation antibody therapeutics for the treatment of cancer. Symphogen is d ... more

Find other employees at this company (136)

Background Information

Employment History

President for Research and Development, Chief Scientific Officer

Enzon Pharmaceuticals , Inc.

Chief Scientific Officer

Immunomedics , Inc.

CSO and Chief Marketing Officer

The Global Leaders

Chief Scientific Officer and President of Research and Development

Eznon

National Cancer Institute

Affiliations

Member
American Association for Cancer Research Inc

Fellow
American College of Physicians

Member, Various Committees
American Association for Cancer Research Inc

Member, Editorial Board
Cancer Research

Member, Various Committees
International Union

Member of Advisory Board
Biotechnology Industry Organization

Board Member
Editorial

Member of Advisory Board
All Conferences

Delegate
GDS International Ltd

Education

M.D. degree

University of Komenius

Web References (78 Total References)


Scientific Advisory Board - symphogen

www.symphogen.com [cached]

Ivan D Horak


Executive Management - symphogen

www.symphogen.com [cached]

Ivan D. Horak, MD, FACP Head of Global R&D, Chief Scientific and Medical Officer Prior to joining Symphogen, Dr. Horak served as President of Research and Development and Chief Scientific Officer of Enzon Pharmaceuticals Inc. Before that, Dr. Horak served as Chief Scientific Officer of Immunomedics, responsible for development of novel antibodies. Dr. Horak has authored over 70 peer-reviewed publications and several book chapters within the fields of hematology, oncology, and immunology and has served on the editorial boards of several scientific journals. Dr. Horak is board certified oncologist. He is Fellow of American College of Physicians and member of American Association for Cancer Research, American Society of Hematology, and American Society Clinical Oncology.


Symphogen - Executive Management

www.symphogen.com [cached]

Ivan D. Horak, MD, FACP Chief Scientific Officer and Medical Officer Prior to joining Symphogen, Dr. Horak served as President of Research and Development and Chief Scientific Officer of Enzon Pharmaceuticals Inc. Before that, Dr. Horak served as Chief Scientific Officer of Immunomedics, responsible for development of novel antibodies. Dr. Horak has authored over 70 peer-reviewed publications and several book chapters within the fields of hematology, oncology, and immunology and has served on the editorial boards of several scientific journals. Dr. Horak is board certified oncologist. He is Fellow of American College of Physicians and member of American Association for Cancer Research, American Society of Hematology, and American Society Clinical Oncology.


Archive - symphogen

www.symphogen.com [cached]

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics (monoclonal, monoclonal mixtures and polyclonal) to treat cancer, infectious and autoimmune diseases, announced today the completion of its senior management team with the addition of a new Chief Scientific/Medical Officer, Ivan D. Horak, M.D.,FACP and a new Chief Business Officer, Gayle M Mills.


Readmore - symphogen

www.symphogen.com [cached]

According to Symphogen Chief Scientific Officer and Medical Officer, Ivan D. Horak, MD, FACP,

Similar Profiles

Other People with this Name

Other people with the name Horak

Terry Horak
Fox Ceramic Tile Inc

Jiri Horak
University of Pennsylvania

Shelly Horak
Texas A&M University

Stephen Horak
STP Nuclear Operating Company

Julie Horak
Cartus Corporation

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory